YuanBio Venture Capital, also known as bioVenture, has filed with the US Securities and Exchange Commission (SEC) to raise a new fund that is likely to continue to invest in life sciences and healthcare companies.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
